Skip to main content
. 2014 May;58(5):2775–2780. doi: 10.1128/AAC.01527-13

FIG 2.

FIG 2

Numbers of patients at risk of IFI during the 120 days after first remission-induction chemotherapy. Patients were stratified on the basis of the current prophylaxis agent, which was treated as a time-dependent covariate.